Details of Metabolite
| Full List of Protein(s) Regulating This Metabolite | ||||||
|---|---|---|---|---|---|---|
| Hydrolases (EC 3) | ||||||
| GTPase KRas (KRAS) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Overexpression of KRAS | |||||
| Induced Change | Uridine triphosphate concentration: decrease (FC = 0.43) | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Lung cancer [ICD-11: 2C25] | |||||
| Details | It is reported that overexpression of KRAS leads to the decrease of uridine triphosphate levels compared with control group. | |||||
| Mitochondrial carrier (MC) | ||||||
| Solute carrier family 25 member 33 (SLC25A33) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] | ||||
| Introduced Variation | Recombinant protein addition of SLC25A33 | |||||
| Induced Change | Uridine triphosphate concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Healthy individual | |||||
| Details | It is reported that recombinant protein addition of SLC25A33 leads to the increase of uridine triphosphate levels compared with control group. | |||||
| Solute carrier family 25 member 36 (SLC25A36) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] | ||||
| Introduced Variation | Recombinant protein addition of SLC25A36 | |||||
| Induced Change | Uridine triphosphate concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Healthy individual | |||||
| Details | It is reported that recombinant protein addition of SLC25A36 leads to the increase of uridine triphosphate levels compared with control group. | |||||
| Transcription factor (TF) | ||||||
| Myc proto-oncogene protein (MYC) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] | ||||
| Introduced Variation | Knockdown (siRNA) of MYC | |||||
| Induced Change | Uridine triphosphate concentration: decrease | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Colorectal cancer [ICD-11: 2B91] | |||||
| Details | It is reported that knockdown of MYC leads to the decrease of uridine triphosphate levels compared with control group. | |||||
| Transferases (EC 2) | ||||||
| Arylamine N-acetyltransferase 1 (NAT1) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[4] | ||||
| Introduced Variation | Knockout of NAT1 | |||||
| Induced Change | Uridine triphosphate concentration: decrease (FC = 0.04) | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Breast cancer [ICD-11: 2C60] | |||||
| Details | It is reported that knockout of NAT1 leads to the decrease of uridine triphosphate levels compared with control group. | |||||
| Isoprenylcysteine carboxylmethyltransferase (ICMT) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[5] | ||||
| Introduced Variation | Inhibition (Cysmethynil) of ICMT | |||||
| Induced Change | Uridine triphosphate concentration: decrease | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Prostate cancer [ICD-11: 2C82] | |||||
| Details | It is reported that inhibition of ICMT leads to the decrease of uridine triphosphate levels compared with control group. | |||||
| Pyridoxal kinase (PDXK) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[6] | ||||
| Introduced Variation | Knockout (CRISPR/Cas9 sgRNA) of Pdxk | |||||
| Induced Change | Uridine triphosphate concentration: decrease | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Acute myeloid leukaemia [ICD-11: 2A60] | |||||
| Details | It is reported that knockout of Pdxk leads to the decrease of uridine triphosphate levels compared with control group. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.


